Keyword: Novartis

World Health Organization (WHO)

3. Egaten

Although triclabendazole has been used for years to treat parasitic infections in animals, Novartis brought the drug to its first FDA nod.
Zolgensma

11. Zolgensma

A one-time medicine intended to cure patients, Zolgensma scored an endorsement from cost watchdogs at ICER despite the record price.
Beovu drug box

28. Beovu

Novartis' Beovu scored an approval in October to challenge Regeneron and Roche blockbusters in wet age-related macular degeneration.
Adakveo

35. Adakveo

Adakveo is the first targeted therapy for vaso-occlusive crises—the painful clumps of sickled red blood cells that can block the flow of oxygen to organs—in patients with sickle cell disease.
Novartis headquarters

6. Mayzent

Mayzent was the first multiple sclerosis drug to be cleared in the secondary progressive form of the disease in more than 15 years.